Case-Based Roundtable Meetings Spotlight August 2021: Solid Tumors

Roundtable Roundup: Polling Physicians on Timing of Durvalumab in NSCLC

September 06, 2021

Clinical Articles

During separate virtual live events, David R. Gandara, MD, and Alexander Spira, MD, PhD, discussed the timing of durvalumab in non–small cell lung cancer from the PACIFIC trial with participating physicians.

Roundtable Discussion: Antonoff Discusses Treatment Goals in NSCLC

September 04, 2021

Clinical Articles

An otherwise healthy 60-year-old woman, who has quit smoking for 8 years after 13 pack years, presented with a nonproductive cough. The patient was diagnosed with non–small cell lung cancer. Oncologists discuss the scenario during a Case-Based Roundtable event.

Roundtable Discussion: Oh and Participants Compare Second- and Third-Line Treatments for mCRPC

August 30, 2021

Clinical Articles

In a 75-year-old patient with metastatic castration-resistant prostate cancer, a bone scan taken at 14-month follow-up showed evidence of 2 lesions in the right hip/pelvis, and abdominal/pelvic CT showed a 2.1-cm left pelvic lymphadenopathy.

Bekaii-Saab Covers Trials in the Second Line for a Patient With CRC

August 28, 2021

Clinical Articles

Tanios S. Bekaii-Saab, MD, professor, discussed the factors that may influence treatment for a 50-year-old patient with KRAS/BRAF wild-type colorectal cancer as well as the treatment options available.

Roundtable Discussion: Looking at the Use of Primary and Switch Maintenance Therapy for Advanced Bladder Cancer

August 25, 2021

Clinical Articles

In treating patients with bladder cancer, criteria for treatment differ across practices. Ten oncologists from community practices and academia discussed how they would approach treatment of a 66-year old man with advanced bladder cancer.